BECKEY BUCK: Open Payments
NPI 1033585930 · ETOWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 17 payments from 7 companies in 2025. Trend: 2023 $989 · 2024 $774 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $159 |
| Alkermes, Inc. | 2 | $40 |
| Neos Therapeutics, LP | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
Products named: Auvelity, LYBALVI, Qelbree, CAPLYTA, EXXUA, COBENFY, Adzenys XR-ODT, VRAYLAR.
Industry payments across TN — which companies pay providers there.
